Assessment of disease activity by clinical parameters in ulcerative colitis is still controversial. Different clinical indexes have been proposed. Colonoscopy provides detailed information on mucosal damage. The aim of this study was to identify, among 21 clinical and laboratory parameters, which were predictive of endoscopic activity. We included 137 consecutive patients with ulcerative colitis who underwent colonoscopy, clinical examination, and blood tests within 4 weeks. Endoscopic severity was recorded using a simple score (range, 0–30). The multiple stepwise regression coefficient of each significant variable predictive of mucosal damage was used to develop a new activity index predictive of endoscopic appearance (Endoscopic–Clinical Correlation Index; ECCI). We tested the ability of our score to discriminate patients with severe endoscopic disease, calculating the area under the receiver operator characteristic curve, and we compared it to activity indexes proposed by other authors. Endoscopic severity was significantly influenced by four parameters: bloody stool, nocturnal bowel movements, body temperature >37.5°C, and serum albumin. The new scoring system was calculated as ECCI = {[serum albumin × (−26)] + (bloody stool × 17) + (nocturnal bowel movements × 16) + [fever (0 or 1) × 39]} + 107. The ECCI accurately identified patients with severe endoscopic disease in our sample (sensitivity = 81%, specificity = 95%). In conclusion, the ECCI should be useful in clinical practice because it is simple and strongly related to endoscopic activity.
Similar content being viewed by others
References
Truelove SC, Witts LJ: Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 2:1041–1048, 1955
Powell-Tuck J, Bown RL, Lennard-Jones JE: A comparison of oral prednisone given as single or multiple daily doses for active proctocolitis. Scand J gastroenterol 13:833–837, 1978
Seo M, Okada M, Yao T, et al.: An index of disease activity in patients with ulcerative colitis. Am J Gastroent 87:971–976, 1992
Walmsley RS, Ayres RCS, Pounder RE, et al.: A simply colitis activity index. Gut 43:29–32, 1998
Maratka Z, Nedbal J, Kocianova J, et al.: Incidence of colorectal cancer in proctocolitis: A retrospective study of 959 cases over 40 years. Gut 26:43–49, 1985
D’Haens GR, Lachner BA, Hanauer SB: Pericolangitis and primary sclerosing cholangitis are risk factor for displasia and cancer in ulcerative colitis. Am J Gastroenterol 88:1174–1178, 1993
Itzkowitz SH: Inflammatory bowel disease and cancer. Gastroenterol Clin North Am 26:129–139, 1997
Nuako KW, Ahlquist DA, Mahoney DW, et al.: Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study. Gastroenterology 115:1079–1083, 1998
Eaden J, Abrams K, Ekbom A, et al.: Colorectal cancer prevention in ulcerative colitis: A case–control study. Aliment Pharmacol Ther 14:145–153, 2000
Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843, 1983
Kornbluth A, Sachar D: Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 92:204–211, 1997
Froehlich F, Larequi-Lauber T, Gonvers J-J, et al.: Appropriateness of colonoscopy: Inflammatory bowel disease. Endoscopy 31:647–653, 1999
Lee SD, Cohen RD: Endoscopy in inflammatory bowel disease. Gastroenterol Clin Na Am 31:119–132, 2002
Isgar B, Harman M, Kaye MD, et al.: Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 24:190–192, 1983
Simrèn M, Axelsson J, Gillberg R, et al.: Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97:389–396, 2002
Rizzello F, Gionchetti P, Venturi C, et al.: Review article: Monitoring activity in ulcerative colitis. Aliment Pharmacol Ther 16(Suppl. 4):3–6, 2002
Baron JH, Connel AM, Lennard-Jones JE: Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1:89–92, 1964
Kim B, Barnett JL, Kleer CG, et al.: Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol 94(11):3258–3262, 1999
Bernstein CN, Shanahan F, Anton P, et al.: Patchiness of mucosal inflammation in treated ulcerative colitis. A prospective study. Gastrointest Endosc 42:232–237, 1995
ASGE: The role of colonoscopy in the management of patients with inflammatory bowel disease. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 48(6):689–690, 1998
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Azzolini, F., Pagnini, C., Camellini, L. et al. Proposal of a New Clinical Index Predictive of Endoscopic Severity in Ulcerative Colitis. Dig Dis Sci 50, 246–251 (2005). https://doi.org/10.1007/s10620-005-1590-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-1590-4